NC
Neurocompute
AI-powered research intelligence
 Partner With Us →
Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 40,199 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

Explore Platform → See latest papers
40,199 Papers indexed
1,440 Papers AI scored
40,199 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.
LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
LATEST PEDIATRIC CANCER PAPERS

Database feed

Last ingest 2026-11-07 10:15 AM
1 Social Determinants of Sleep Health in Survivors of Childhood Cancer: A Systematic Review. Journal of sleep research — Nov 07, 2026 2 Primitive neuroectodermal tumour of the left posterior mandible. BMJ case reports — Nov 07, 2026 3 Adrenal ganglioneuroma in an adolescent presenting as an incidentaloma: Imaging-pathology correlation and diagnostic challenges: A case report. Medicine — Nov 07, 2026 4 Synchronous hepatocellular carcinoma and nasopharyngeal carcinoma in a patient with chronic hepatitis B: A case report and literature review. Medicine — Nov 07, 2026 5 Prenatal Trio Exome Sequencing in Low-Risk Pregnancies: Diagnostic Yield and Clinical Implications. Clinical genetics — Nov 07, 2026 6 Defining and validating an HPV vaccination motivation score in Kenya and Malawi: A tool for use in low- and middle-income countries. Vaccine — Nov 07, 2026 7 Drawing the Sacred: Visualizing Where Hope Lives in Hispanic Adolescent and Young Adult Cancer Survivorship. Journal of adolescent and young adult oncology — Nov 07, 2026 8 Social Isolation in Japanese Adolescents and Young Adults with Hematologic Malignancies: A Focus on Peer Relationships and Occupational Therapy Implications. Journal of adolescent and young adult oncology — Nov 07, 2026
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

40199 results
C
A Narrative Review of Pain in Pediatric Oncology: The Opioid Option.
PMID 38954225 Published: 2024-07-02 Ingested: 2026-08-02 12:02 AM Paediatric drugs
AI -
Standard 55.4
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.4/100. Study design: 55.0; human relevance: 70.0; therapeutic relevance: 22.0; sample size: 60.0; recency: 80.0; abstract quality: 65.0.

C
The Not-So-Good Cancer: Psychosocial Challenges for YA Thyroid Cancer Patients and Survivors and the Creation of a YA Thyroid Cancer Support Group.
PMID 38682360 Published: 2024-04-29 Ingested: 2026-08-02 12:02 AM Journal of adolescent and young adult oncology
AI -
Standard 55.4
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.4/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 27.0; sample size: 20.0; recency: 80.0; abstract quality: 65.0.

C
POEM from A to Z: current perspectives.
PMID 37073708 Published: 2025-01-01 Ingested: 2026-08-02 12:03 AM Revista espanola de enfermedades digestivas
AI -
Standard 55.4
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.4/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 22.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

C
High dose rate brachytherapy for vaginal rhabdomyosarcoma in a 10-month-old child using custom-made multi-channel applicator: Initial experience and challenges.
PMID 40214356 Published: 2025-04-02 Ingested: 2026-08-02 12:03 AM Journal of cancer research and therapeutics
AI -
Standard 55.36
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.4/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 34.3; sample size: 20.0; recency: 90.0; abstract quality: 40.0.

C
Lymphoblasts Express Hemostatic Factors: A Mechanism for Hypercoagulability in Pediatric Acute Lymphoblastic Leukemia.
PMID 41086867 Published: 2025-10-14 Ingested: 2026-08-02 12:05 AM Thrombosis and haemostasis
AI -
Standard 55.35
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.4/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 36.8; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

C
Biological Activity of Biomarkers Associated With Metastasis in Osteosarcoma Cell Lines.
PMID 40079158 Published: 2025-03-01 Ingested: 2026-08-02 12:04 AM Cancer medicine
AI -
Standard 55.35
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.4/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 41.8; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

C
Molecular mechanism of portal hypertensive gastropathy: An update.
PMID 39032917 Published: 2024-07-19 Ingested: 2026-08-02 12:02 AM Clinics and research in hepatology and gastroenterology
AI -
Standard 55.35
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.4/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 16.8; sample size: 20.0; recency: 80.0; abstract quality: 85.0.

C
Identification of the Shared Gene Signatures of HCK, NOG, RNF125 and Biological Mechanism in Pediatric Acute Lymphoblastic Leukaemia and Pediatric Sepsis.
PMID 38123749 Published: 2023-12-20 Ingested: 2026-08-02 12:03 AM Molecular biotechnology
AI -
Standard 55.35
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.4/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 16.8; sample size: 20.0; recency: 80.0; abstract quality: 85.0.

C
NQO1‑activated self‑reinforcing bimetallic nanoplatform triggers ferroptosis and cuproptosis for osteosarcoma therapy.
PMID 42696813 Published: 2026-09-02 Ingested: 2026-09-06 09:15 AM Colloids and surfaces. B, Biointerfaces
AI -
Standard 55.34
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.3/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 44.2; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Exon-skipping antisense oligonucleotides for H3.3K27M-altered diffuse midline glioma therapy.
PMID 42656813 Published: 2026-07-27 Ingested: 2026-08-29 09:15 AM Molecular therapy. Nucleic acids
AI -
Standard 55.34
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.3/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 44.2; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Dysregulation of Human ClpP Using Small Molecules with Piperazine-Based Scaffold for Diffuse Intrinsic Pontine Glioma Therapy Validated by Patient-Derived Tumor Organoids.
PMID 42418817 Published: 2026-07-08 Ingested: 2026-08-02 12:07 AM Journal of medicinal chemistry
AI -
Standard 55.34
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.3/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 44.2; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Exon-Skipping Antisense Oligonucleotides for H3.3K27M-Altered Diffuse Midline Glioma Therapy.
PMID 41959111 Published: 2026-04-04 Ingested: 2026-08-02 12:06 AM bioRxiv : the preprint server for biology
AI -
Standard 55.34
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.3/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 44.2; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

Previous
Page 2594 of 3350
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.
Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic